Fundraising Fox
Bart Rossel
InvestorScientific Advisor and Advisory Board Member, Novalis Biotech Incubation Fund; Supervisory Board Member of Novalis at Novalis Biotech
Find your path to Bart
Sign up to see every warm intro you have to Bart
- Paths you didn't know you had: your email and LinkedIn already hold routes to Bart. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Bart Rossel is a bio-engineer by training who has worked in the agro and life science sectors and held several management roles. In 2002, he and his team acquired the pharmaceutical company Oystershell Laboratories, which they sold to Gilde Buy Out Partners in 2017. He holds several patents and authored a book about insects.
Invests in
BiotechConsumer
Colleagues at Novalis Biotech
Frequently asked questions
- Who is Bart Rossel?
- Bart Rossel is a bio-engineer by training who has worked in the agro and life science sectors and held several management roles. In 2002, he and his team acquired the pharmaceutical company Oystershell Laboratories, which they sold to Gilde Buy Out Partners in 2017. He holds several patents and authored a book about insects.
- Where does Bart Rossel work?
- Bart Rossel is Scientific Advisor and Advisory Board Member, Novalis Biotech Incubation Fund; Supervisory Board Member of Novalis at Novalis Biotech.
- What does Bart Rossel invest in?
- Bart Rossel invests in Biotech, Consumer.
About this profile. Compiled from public sources — Novalis Biotech's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights